Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Unoprostone is a prostaglandin F2α analogs (PGAs), and reduces intraocular pressure and is used topically for glaucoma or ocular hypertension.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 153.00 | |
5 mg | 35 days | $ 660.00 | |
10 mg | 35 days | $ 1,170.00 | |
50 mg | 35 days | $ 4,650.00 |
Description | Unoprostone is a prostaglandin F2α analogs (PGAs), and reduces intraocular pressure and is used topically for glaucoma or ocular hypertension. |
In vitro | Pretreatment with Unoprostone (0.01, 0.1, 1 μM; 1 hour before H2O2 treatment) prevents H2O2-induced cell death in a concentration-dependent manner, and the effect is significant at 0.1 μM and 1 μM concentrations[1]. Pretreatment with Unoprostone at a concentration of 0.1 to 3 μM can prevent light-induced cell death in a concentration-dependent manner; the effect is significant at 1 and 3 μM. Unoprostone reduces the morphological change, and it significantly inhibits the low mitochondrial membrane potential and cell death induced by light irradiation[1]. Unoprostone has prostaglandin F2α receptors (FP) binding affinity (Ki of 3.86 μM)[2]. |
Molecular Weight | 382.53 |
Formula | C22H38O5 |
CAS No. | 120373-36-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Unoprostone 120373-36-6 Others inhibitor inhibit